Active ingredientTucatinibCat. No. P-T234-001CAS 937263-43-9Family · Pharmaceutical analytical standards
Tucatinib
A highly selective oral HER2 tyrosine kinase inhibitor, approved in the United States in 2020 for metastatic HER2-positive breast cancer, including when it has spread to the brain. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was the first new medicine approved under Project Orbis, in which the regulators of the United States, Australia, Canada, Singapore and Switzerland reviewed the application together.
Go to the active ingredient →Active ingredientTucatinibCat. No. P-T234-001CAS 937263-43-9
Isotopically labelledTucatinib Impurity 6-d4Cat. No. P-T234-002
Isotopically labelledTucatinib Impurity 8-d6Cat. No. P-T234-003
Isotopically labelledTucatinib-d6Cat. No. P-T234-004
Impurity2-(hydroxyamino)-2-methylpropan-1-olCat. No. P-T234-006CAS 4706-13-2
ImpurityTucatimib intennediateCat. No. P-T234-007CAS 937263-71-3
ImpurityTucatinib Impurity 1Cat. No. P-T234-008
ImpurityTucatinib Impurity 2Cat. No. P-T234-009
ImpurityTucatinib Impurity 3Cat. No. P-T234-010
ImpurityTucatinib Impurity 4Cat. No. P-T234-011
ImpurityTucatinib Impurity 5Cat. No. P-T234-012CAS 1429755-57-6
ImpurityTucatinib Impurity 6Cat. No. P-T234-013CAS 937263-81-5
ImpurityTucatinib Impurity 7Cat. No. P-T234-014CAS 2307628-67-5
ImpurityTucatinib Impurity 8Cat. No. P-T234-015CAS 1429755-58-7
ImpurityTucatinib Impurity 9Cat. No. P-T234-016CAS 80782-82-7
ImpurityTucatinib Impurity 10Cat. No. P-T234-017
ImpurityTucatinib Impurity 11Cat. No. P-T234-018
ImpurityTucatinib Thiazolyl ImpurityCat. No. P-T234-019CAS 937266-01-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.